The Conflict in Ethiopia: Actors, Causes, and Dynamics

The conflict in Ethiopia is not a single war but rather a collection of overlapping conflicts involving the federal government, regional nationalist movements, ethnic militias, and neighboring states. The principal areas of conflict are Tigray, Amhara, and Oromia, creating a complex security crisis with implications for the entire Horn of Africa.

Historical Background

The roots of the current crisis lie in Ethiopia's political transition after 2018. For decades, the Tigray People's Liberation Front (TPLF) dominated Ethiopia's governing coalition. When Prime Minister Abiy Ahmed came to power in 2018, he reorganized the political system and created the Prosperity Party. The TPLF rejected these changes and remained politically entrenched in the Tigray region. Political tensions over authority, elections, and federal-regional relations eventually escalated into armed conflict in November 2020.

The resulting Tigray War lasted until the Pretoria Peace Agreement of November 2022. While the agreement ended major hostilities, important disputes involving territorial control, security arrangements, and accountability for wartime abuses remained unresolved.

Main Actors

1. Ethiopian Federal Government

The federal government, led by Prime Minister Abiy Ahmed, seeks to preserve national unity and maintain the authority of Addis Ababa over Ethiopia's regional states. Its principal military force is the Ethiopian National Defense Force (ENDF). The government currently faces multiple armed movements operating across several regions.

Objectives

• Preserve Ethiopia's territorial integrity.
• Maintain federal authority.
• Defeat regional insurgencies.
• Prevent fragmentation of the state.

2. Tigray People's Liberation Front (TPLF)

The TPLF was the dominant political force in Ethiopia from 1991 until 2018. After losing national power, it became the principal challenger to the federal government in Tigray. Its military wing, commonly known as the Tigray Defense Forces (TDF), fought the federal government during the 2020-2022 war. Although peace was formally established in 2022, tensions and periodic clashes have continued.

Objectives

• Greater autonomy for Tigray.
• Protection of Tigrayan political interests.
• Resolution of disputed territorial claims.
• Implementation of outstanding provisions of the Pretoria Agreement.

3. Fano Militias (Amhara)

Fano refers to a loose network of Amhara nationalist militias rather than a single centralized organization. During the Tigray War, many Fano groups fought alongside the federal government against the TPLF. After the war, relations between the Fano movement and Addis Ababa deteriorated, leading to an insurgency in the Amhara region.

Objectives

• Defend Amhara regional interests.
• Maintain claims to disputed territories.
• Resist perceived federal encroachment.
• Protect Amhara communities.

One of the most notable developments has been the emergence of tactical cooperation between some former enemies, including elements associated with both the TPLF and Fano, despite their previous battlefield conflict.

4. Oromo Liberation Army (OLA)

The Oromo Liberation Army operates primarily in Oromia, Ethiopia's largest regional state and home to the country's largest ethnic group, the Oromo. The OLA has been engaged in armed conflict with federal forces since 2018. The government considers the OLA a terrorist organization, while the movement argues it is fighting for Oromo political rights and self-determination.

Objectives

• Greater Oromo autonomy.
• Political reforms within Ethiopia.
• Protection of Oromo interests.
• Expanded regional self-governance.

5. Eritrea

Eritrea is the most significant external actor in the Ethiopian conflict. During the Tigray War, Eritrean forces fought alongside Ethiopia's federal government against the TPLF. More recently, relations have become increasingly complex, with Ethiopia accusing Eritrea of supporting armed groups opposed to Prime Minister Abiy Ahmed. Eritrea denies those accusations.

Strategic Interests

• Limiting TPLF influence.
• Maintaining regional security leverage.
• Protecting national interests along the border.

6. Other Armed Movements

Several smaller organizations also play important roles in Ethiopia's security landscape. Some have recently joined wider anti-government coalitions.

• Ogaden National Liberation Front (ONLF)
• Afar Revolutionary Democratic Unity Front
• Benishangul People's Liberation Movement
• Gumuz People's Democratic Movement

Why the Conflict Is So Complex

The Ethiopian conflict combines multiple overlapping disputes rather than a single cause.

• Federal authority versus regional autonomy.
• Competing ethnic nationalisms.
• Control of disputed territories.
• Economic grievances.
• Historical rivalries among ethnic groups.
• Influence from neighboring states, particularly Eritrea.

These overlapping disputes create a shifting system of alliances. Groups that fought each other during one phase of the conflict have sometimes become temporary partners against a common adversary. This fluidity makes the conflict difficult to categorize as a conventional civil war.

The Bigger Picture

At its core, Ethiopia's crisis is a struggle over how political power should be distributed within one of Africa's largest and most ethnically diverse states. The federal government seeks to preserve centralized authority and national unity, while regional movements advocate varying degrees of autonomy, self-government, and influence. The result is a fragmented conflict involving multiple fronts, competing national visions, and shifting alliances.

Understanding Ethiopia's ethnic federal system is essential to understanding the conflict itself. Many of today's armed movements are rooted in competing views about the balance of power between regional identities and the Ethiopian state.

SSI, PASS, Medi-Cal, and Earnings Interaction for a Returning Worker

This document explains how a California SSI recipient earning $1,250 per month can return to work earning $30,000 per year under a PASS plan, how Medi-Cal responds, and how much combined income can be kept. The analysis follows federal SSI income rules, PASS exclusions, and California Medi-Cal continuity protections.

1. Baseline: SSI at $1,250 per Month

An SSI payment of $1,250 per month indicates that you are receiving the California State Supplement in addition to the federal SSI benefit. This level of payment means you are fully eligible for free, full-scope Medi-Cal. Medi-Cal eligibility is automatic for SSI recipients and does not require a separate income test.

2. Returning to Work at $30,000 per Year

Working three-quarter time at $30,000 per year produces gross monthly earnings of approximately $2,500. Under normal SSI rules, this level of income would sharply reduce or eliminate SSI cash benefits. However, the PASS program allows you to set aside income for a work goal, and income set aside under PASS is completely excluded from SSI income calculations. This exclusion applies to both earned and unearned income.

3. PASS Program Effect on Countable Income

PASS allows you to designate part of your earnings toward a vocational goal. Any amount placed into the PASS plan is not counted by SSI. If you set aside enough of your $2,500 monthly earnings, your countable income can be reduced to the level that preserves your full SSI payment. In practice, you can shelter nearly all of your earnings under PASS if the work goal is legitimate and documented. This means your SSI payment of $1,250 can continue unchanged.

The PASS program therefore allows you to keep both your SSI payment and your work earnings, minus only the portion you voluntarily set aside for the PASS plan. The set-aside funds are still yours; they are simply restricted for the approved work goal.

4. Medi-Cal Continuity Under PASS and Earnings

Medi-Cal remains fully intact. California law guarantees that anyone receiving SSI continues to receive free full-scope Medi-Cal regardless of earnings. Because PASS preserves SSI eligibility, Medi-Cal coverage does not change. Even if SSI cash payments were reduced, California’s 1619(b) protections allow continued Medi-Cal eligibility up to very high earnings thresholds, far above $30,000 per year.

Therefore, your Medi-Cal coverage remains uninterrupted and free while you work under PASS.

5. Total Income You Can Keep

Your total monthly gross earnings are $2,500. Your SSI payment is $1,250. Under PASS, you can keep the full SSI amount and all earnings except the portion you choose to allocate to the PASS plan. If your PASS plan requires $1,000 per month toward your work goal, you would keep $1,500 in cash earnings plus your $1,250 SSI, for a total of $2,750 per month. If your PASS plan requires less, you keep more. If your PASS plan shelters nearly all earnings, you still retain the funds but they must be used for the approved goal.

In practical terms, your maximum keepable income is the full SSI payment plus the full $2,500 in earnings, with the PASS allocation functioning as a temporary restriction rather than a loss. This means your effective monthly resources can approach $3,750, depending on the PASS structure.

6. Social Security Work Credits

You are four years away from paying into Social Security again. Earnings under PASS still count toward Social Security work credits. The PASS exclusion applies only to SSI income calculations and does not affect Social Security payroll tax contributions. Therefore, your return to work rebuilds your future Social Security retirement and disability eligibility even while PASS protects your SSI and Medi-Cal.

7. Summary

Under a PASS plan, you can return to work earning $30,000 per year while keeping your full SSI payment and maintaining uninterrupted Medi-Cal coverage. The PASS program allows you to exclude most or all earnings from SSI calculations, preserving your benefits. Your total keepable income consists of your SSI payment plus your earnings, minus only the portion allocated to the PASS plan, which remains your money for the approved work goal. Your Social Security work credits also resume, strengthening future eligibility.

Financial Toxicity in U.S. Cancer Care

This document explains why 42 percent of U.S. cancer patients lose all their wealth within two years of diagnosis and quantifies the average amount of money lost. The analysis draws on peer‑reviewed health‑economic research, including the American Journal of Medicine’s landmark study on cancer‑related financial toxicity.

Wealth Loss Among Cancer Patients

Research shows that 42.4 percent of cancer patients deplete their entire life savings within two years of diagnosis. This phenomenon is known as financial toxicity, a term used to describe the severe economic burden imposed by cancer treatment, supportive care, and associated nonmedical costs.

The average amount of wealth lost within two years is $92,098. This figure represents the typical depletion of savings, retirement accounts, and liquid assets among middle‑income households facing cancer treatment.

Is This Due to Lack of Insurance?

The loss of wealth is not primarily due to lack of insurance. In fact, most patients in the study were insured through employer plans, Medicare, or Medicaid. The problem is underinsurance, meaning that insurance coverage is insufficient to protect patients from catastrophic financial harm.

Insurance fails to prevent wealth loss for several reasons. High deductibles and copayments for chemotherapy, radiation, surgery, imaging, and supportive medications create substantial out‑of‑pocket obligations. Nonmedical costs such as travel, lodging, and caregiver time are not covered by insurance. Additionally, many patients experience significant income loss due to reduced work capacity or job loss during treatment.

Thus, the financial devastation arises from the structure of U.S. insurance systems rather than from lack of coverage.

Drivers of Financial Collapse

The following factors contribute to the rapid depletion of wealth among cancer patients:

Driver	Description	Impact
High Out‑of‑Pocket Costs	Deductibles, copayments, coinsurance for chemotherapy, radiation, surgery, imaging, and medications	Large immediate financial burden even with insurance
Nonmedical Expenses	Travel, lodging near treatment centers, caregiver time, household support	Not covered by insurance; adds thousands in additional costs
Income Loss	Reduced work capacity or job loss during treatment	Sharp decline in household earnings
High Drug Prices	Modern oncology drugs often cost $100,000+ per year	Insurance cost‑sharing remains substantial

Summary

Forty‑two percent of cancer patients lose all their wealth within two years, with an average loss of $92,098. This outcome is driven by underinsurance, high treatment costs, nonmedical expenses, and income loss. Insurance coverage does not adequately protect patients from the economic consequences of cancer treatment.

What “Payout Status” Means for an IRA When a Senior Applies for Medicaid Long-Term Care

“Payout status” is a Medicaid-specific term describing how retirement accounts are treated when a senior applies for long-term care coverage. Medicaid distinguishes between retirement accounts that are being actively distributed and those that are not. This distinction determines whether the IRA is counted as an asset that must be spent down or whether it is exempt and allowed to remain intact.

1. Core Definition of Payout Status

An IRA is considered in payout status when the owner is receiving regular, periodic distributions from the account. These distributions must be scheduled, ongoing, and actuarially reasonable. Medicaid evaluates whether the IRA is being treated as a true retirement income source rather than a liquid asset available for spend-down.

If the IRA is in payout status, Medicaid counts only the monthly distribution as income. The principal inside the IRA is exempt and does not need to be spent down. This allows seniors to preserve the IRA while qualifying for long-term care coverage.

2. How Seniors Enter Payout Status

Seniors automatically enter payout status when they begin taking Required Minimum Distributions (RMDs). Federal law requires RMDs beginning at age 73. Once RMDs begin, the IRA is considered in payout status for Medicaid purposes. Seniors may also voluntarily elect periodic distributions that meet Medicaid’s criteria even before RMD age.

Medicaid requires that distributions be periodic and actuarially sound. This means the payout schedule must be consistent with life expectancy tables and cannot be structured to delay distributions indefinitely. Monthly, quarterly, or annual distributions all qualify as long as they follow a reasonable schedule.

3. Why Payout Status Matters for Medicaid Eligibility

Medicaid distinguishes between countable and exempt assets. Retirement accounts in payout status are treated as exempt assets. Only the income generated from the distributions is counted toward Medicaid’s income rules. This allows seniors to preserve the principal in their retirement accounts while still qualifying for long-term care coverage.

If an IRA is not in payout status, Medicaid treats the entire account as a countable resource. This means the IRA may need to be liquidated and spent down to meet Medicaid’s asset limits. Entering payout status prevents liquidation and protects the IRA.

4. Treatment of IRAs for Married Couples

When one spouse enters long-term care and the other remains in the community, the community spouse’s IRA is fully exempt regardless of payout status. Medicaid does not count the community spouse’s retirement accounts toward eligibility. The institutionalized spouse’s IRA must be in payout status to be exempt.

If both spouses enter long-term care, each IRA must be evaluated individually. IRAs in payout status remain exempt. IRAs not in payout status may be counted and may require conversion to payout status to avoid spend-down.

5. Practical Example for a Senior

A senior age 75 with a $50,000 IRA is already required to take RMDs. Because the IRA is in payout status, Medicaid counts only the monthly RMD amount as income. The $50,000 principal remains protected and does not need to be spent down. This allows the senior to qualify for long-term care coverage while preserving the IRA.

If the senior were younger than 73 and not taking distributions, Medicaid would treat the entire $50,000 as a countable asset. The senior could elect periodic distributions to place the IRA in payout status and protect the principal.

6. Overall Meaning of Payout Status

Payout status is a protective classification that allows seniors to preserve retirement accounts during Medicaid long-term care eligibility. By ensuring that the IRA is in payout status, seniors can avoid liquidation and maintain the principal while receiving long-term care coverage. This status is essential for asset preservation and financial stability during long-term care.

Nevada Medicaid Treatment of Home and IRA for Couples Age 65+ Entering Skilled Nursing, Custodial Care, or Cancer Treatment

This document explains how Nevada Medicaid evaluates a $500,000 home and a $50,000 IRA when one or both spouses age 65 or older enter skilled nursing, custodial care, or require cancer treatment. Nevada follows federal Medicaid long-term care rules, including spousal impoverishment protections, home exemptions, and estate recovery limitations.

1. Treatment of the $500,000 Home

Nevada Medicaid treats the primary residence as an exempt asset as long as one spouse continues living in the home. The value of the home does not matter; Nevada does not impose a home equity cap when a community spouse resides there. If one spouse enters long-term care and the other remains at home, the home is fully protected and cannot be counted toward Medicaid eligibility.

If both spouses enter long-term care simultaneously, the home remains exempt if either spouse expresses an intent to return home. Nevada accepts this intent even if return is medically unlikely. The home therefore remains protected during both spouses’ lifetimes.

Estate recovery in Nevada occurs only after both spouses have died. Recovery applies only to assets passing through probate. If the home is placed in a living trust or otherwise avoids probate, Nevada cannot recover against it. This allows the home to remain protected even after both spouses’ deaths.

2. Treatment of the $50,000 IRA

Nevada follows federal Medicaid rules for retirement accounts. If the IRA belongs to the community spouse, it is fully exempt and does not count toward Medicaid eligibility. The community spouse may retain the IRA without spend-down requirements.

If the IRA belongs to the spouse entering long-term care, Nevada counts the IRA as a resource unless it is in payout status. When the IRA is in periodic required minimum distribution status, Nevada treats the principal as exempt and counts only the monthly distribution as income. This allows the IRA to be preserved rather than liquidated.

If both spouses enter long-term care, each IRA must be evaluated individually. IRAs in payout status remain protected. IRAs not in payout status may be counted and may require conversion to payout status to avoid spend-down.

3. Spousal Impoverishment Protections

Nevada applies federal spousal impoverishment rules when one spouse enters long-term care. The community spouse is allowed to retain a significant portion of the couple’s assets under the Community Spouse Resource Allowance. In 2026, the community spouse may keep approximately $154,000 in countable assets, in addition to exempt assets such as the home and retirement accounts.

The community spouse also retains all personal income. None of the community spouse’s income is taken to pay for the institutionalized spouse’s care. The institutionalized spouse contributes income toward the cost of care, minus a small personal needs allowance.

4. If Both Spouses Enter Skilled Nursing or Custodial Care

When both spouses enter long-term care, Nevada Medicaid evaluates them as a couple. The home remains exempt if either spouse intends to return home. The IRA remains exempt if in payout status. Countable assets must be reduced to the couple’s Medicaid resource limit, which is significantly lower than the spousal impoverishment allowance. Exempt assets, including the home and properly structured IRAs, remain protected.

After both spouses pass away, Nevada may pursue estate recovery. Recovery applies only to probate assets. If the home is held in a living trust or passes outside probate, Nevada cannot recover against it.

5. Cancer Treatment Under Nevada Medicaid

Cancer treatment falls under standard Medicaid medical coverage rather than long-term care rules. Asset limits for medical Medicaid differ from long-term care Medicaid. However, for individuals age 65 and older, Nevada uses the federal SSI-related Medicaid rules, which include asset limits but exempt the home and certain retirement accounts. The $500,000 home remains protected. The $50,000 IRA is exempt if in payout status.

If cancer treatment leads to long-term custodial care, the long-term care rules described above apply.

6. Summary Table

Asset	Outcome When One Spouse Enters Care	Outcome When Both Spouses Enter Care
Home ($500,000)	Fully exempt; protected; no spend-down; no lien; no recovery while community spouse lives.	Exempt if either spouse intends to return; protected until both spouses die; avoid probate to prevent recovery.
IRA ($50,000)	Exempt if owned by community spouse; exempt if in payout status for institutionalized spouse.	Exempt if in payout status; may require conversion to payout status to avoid spend-down.
Estate Recovery	No recovery until both spouses have died; home protected while community spouse lives.	Recovery only against probate assets; home protected if placed in trust or otherwise avoids probate.

7. Overall Consequence

In Nevada, a $500,000 home and a $50,000 IRA can both be preserved even if one or both spouses age 65 or older enter skilled nursing, custodial care, or require cancer treatment. The home remains exempt during both spouses’ lifetimes. The IRA remains exempt if properly structured in payout status. Estate recovery can be avoided by ensuring the home does not pass through probate.

Medi-Cal Asset Rules for Cancer Patients Seeking Extra Help

This document explains which assets you may keep and still qualify for Medi-Cal “extra help” programs after a cancer diagnosis. It reflects California’s 2026 Non‑MAGI Medi‑Cal asset rules, including exemptions, countable resources, and special protections for married couples.

Asset Limits for 2026

California reinstated Medi-Cal asset limits on January 1, 2026. The limits are:

Individual: $130,000
Couple: $195,000
Each additional household member: $65,000

These limits apply to Non‑MAGI Medi‑Cal categories, including cancer treatment coverage, long‑term care, and dual‑eligible Medicare + Medi‑Cal programs.

Exempt Assets You May Keep

The following assets do not count toward the Medi-Cal limit and remain fully protected:

Primary Home

Your main residence is exempt as long as you live in it. Its value does not affect eligibility.

One Vehicle

Your primary automobile is exempt regardless of value.

Household Goods and Personal Items

Furniture, clothing, appliances, and personal effects—including jewelry—are excluded.

Retirement Accounts

IRAs and employer-sponsored pensions are exempt if you receive regular periodic payments. For married couples, the community spouse’s retirement accounts are always exempt.

Burial Assets

Exempt burial resources include burial plots, irrevocable prepaid burial plans, and up to $1,500 in designated burial funds.

Business or Self-Support Property

Real property or equipment used for business or self-support does not count toward the limit.

Countable Assets

The following assets do count toward the $130,000 limit:

Cash, checking and savings accounts, stocks, bonds, mutual funds, second vehicles, second homes, and non-exempt financial resources.

Special Rules for Married Couples

If one spouse requires long-term care due to cancer, Medi-Cal applies spousal impoverishment protections:

The institutionalized spouse may keep $130,000.
The community spouse may keep the Community Spouse Resource Allowance (CSRA), which is $162,660 in 2026.

This allows a married household to retain over $290,000 in combined assets while still qualifying.

Upcoming 2027 Change

On July 1, 2027, California’s Medi-Cal asset limit is scheduled to drop sharply:

Individual: $21,000
Couple: $31,000

This change will significantly affect eligibility planning for cancer patients and dual-eligibles.

Comparison Table

Asset Category	Counted?	Notes
Primary Home	No	Fully exempt while occupied
One Vehicle	No	Any value
Retirement Accounts	No (if periodic payments)	Spouse’s IRA always exempt
Burial Assets	No	Plots, prepaid plans, $1,500 fund
Cash / Bank Accounts	Yes	Fully countable
Investments	Yes	Stocks, bonds, mutual funds
Second Home / Vehicle	Yes	Countable
Business Property	No	If used for self-support

International Comparison of Cancer Treatment Costs

Overview

Cancer treatment costs vary dramatically across countries due to differences in healthcare financing, drug pricing regulation, insurance structures, and national reimbursement policies. This document presents a comparative analysis of cancer treatment costs in the United States, the European Union, the United Kingdom, Canada, and Japan, based on 2025–2026 global oncology data.

United States

The United States has the highest cancer treatment costs in the world. New oncology drugs frequently exceed one hundred thousand dollars per year. Multimodal treatment involving surgery, chemotherapy, radiation, immunotherapy, and targeted therapy often ranges from fifty thousand to two hundred thousand dollars. Out-of-pocket costs remain substantial even for insured patients, averaging five thousand dollars annually.

High costs are driven by market-based drug pricing, fragmented insurance systems, and limited government negotiation power.

European Union

The European Union benefits from centralized or semi-centralized drug price negotiations, resulting in significantly lower oncology drug prices. Cancer treatment costs typically range from twenty thousand to sixty thousand dollars. Out-of-pocket expenses are minimal due to universal coverage systems.

Survival outcomes for many cancers are comparable to those in the United States, despite substantially lower costs.

United Kingdom

The United Kingdom’s National Health Service (NHS) provides comprehensive cancer treatment at no direct cost to patients. Drug prices are regulated through the National Institute for Health and Care Excellence (NICE), which evaluates cost-effectiveness before approving therapies.

Total treatment costs to the system typically range from fifteen thousand to fifty thousand dollars. Out-of-pocket costs are negligible.

Canada

Canada’s single-payer system provides universal coverage for hospital-based cancer treatments. Drug costs are lower than in the United States but higher than in the United Kingdom. Total treatment costs generally fall between twenty thousand and seventy thousand dollars.

Out-of-pocket costs vary by province, particularly for outpatient oral cancer drugs, but remain significantly lower than in the United States.

Japan

Japan’s universal health insurance system provides broad coverage for cancer treatment. Drug prices are regulated and frequently adjusted downward. Total treatment costs typically range from twenty thousand to fifty thousand dollars. Patients pay a small co-payment, usually capped by income-based limits.

Japan achieves excellent survival outcomes for many cancers, particularly gastric and colorectal cancers, at relatively low cost.

Comparative Summary Table

Region	Typical Cost Range	Patient Out-of-Pocket Cost	Key Features
United States	Fifty thousand to two hundred thousand dollars	High; averages five thousand dollars annually	Market-based pricing; fragmented insurance; highest global drug costs
European Union	Twenty thousand to sixty thousand dollars	Minimal	Centralized price negotiation; universal coverage
United Kingdom	Fifteen thousand to fifty thousand dollars	Negligible	NICE cost-effectiveness review; NHS universal coverage
Canada	Twenty thousand to seventy thousand dollars	Low to moderate depending on province	Single-payer system; regulated drug prices
Japan	Twenty thousand to fifty thousand dollars	Low; capped by income	Universal insurance; frequent price adjustments